FDA Clearance Tracker · P240013-S025
Sphere-9 Catheter and Affera Ablation System
Last checked: Nov 20, 2026Latest source record: May 15, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 15, 2026
Approved
Time to decision
43 days
Received Apr 2, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P240013-S025
- Device name
- Sphere-9 Catheter and Affera Ablation System
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Apr 2, 2026
- Decided
- May 15, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P240013
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
a new contract manufacturer, a new sterilization site, and a new packaging configuration and material (along with suppliers) for Catheter Extension Cable (Model AFR 00006)
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.